Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Veterinary resources – in clinic (US)

Key Takeaway: Volition has launched a collection of educational materials to promote the Nu.Q® Vet Cancer Test aimed at pet parents. These materials include a poster, trifold brochure, and informational postcards that highlight the importance of early canine cancer screening. Additionally, related press releases discuss the submission of a manuscript for the test in cats and the introduction of an automated version of the test.
Price reaction · baseline $10.814 (2025-04-02 close) · hit pre-market · 4 other VNRX headline(s) in the window, move may be shared
day 0 close
+3.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Educational materials promote awareness of canine cancer screening.
  • The Nu.Q® Vet Cancer Test aims to improve early detection of cancer in dogs.
  • The upcoming publication may unlock a significant milestone payment.

Full Press Release Details

A collection educational materials to promote the Nu.Q ® Vet Cancer Test to pet parents:
• A poster explaining the benefits of canine cancer screening and what dosgs are suitable. Size : US Tabloid
• A trifold brochure to inform and educate pet parents on the importance and benefits of early canine cancer screening. Size : US Letter
• An informational postcard to promote the test and benefits of early canine cancer detection. Size : US Letter
• Social media assets

Related Articles

• Press Releases Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment
• Press Releases Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment

Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the Nu.Q® Vet Cancer Test?

The Nu.Q® Vet Cancer Test is designed for early detection of cancer in dogs.

What educational materials are available?

Materials include a poster, trifold brochure, and postcards promoting the test.

Why is early canine cancer screening important?

Early screening can lead to better outcomes and more effective treatment options.

What milestone payment is associated with the test?

A $5 million milestone payment is expected upon publication of a related study.

Last updated: Apr 3, 2025